FR2543435B1 - Composition antimycosique sous forme de creme au bifonazole, a forte liberation de substance active - Google Patents

Composition antimycosique sous forme de creme au bifonazole, a forte liberation de substance active

Info

Publication number
FR2543435B1
FR2543435B1 FR8404906A FR8404906A FR2543435B1 FR 2543435 B1 FR2543435 B1 FR 2543435B1 FR 8404906 A FR8404906 A FR 8404906A FR 8404906 A FR8404906 A FR 8404906A FR 2543435 B1 FR2543435 B1 FR 2543435B1
Authority
FR
France
Prior art keywords
antimycosic
composition
active substance
high release
bifonazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8404906A
Other languages
English (en)
Other versions
FR2543435A1 (fr
Inventor
Karlheinz Adams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of FR2543435A1 publication Critical patent/FR2543435A1/fr
Application granted granted Critical
Publication of FR2543435B1 publication Critical patent/FR2543435B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FR8404906A 1983-03-30 1984-03-29 Composition antimycosique sous forme de creme au bifonazole, a forte liberation de substance active Expired FR2543435B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311701 DE3311701A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme

Publications (2)

Publication Number Publication Date
FR2543435A1 FR2543435A1 (fr) 1984-10-05
FR2543435B1 true FR2543435B1 (fr) 1988-06-17

Family

ID=6195162

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8404906A Expired FR2543435B1 (fr) 1983-03-30 1984-03-29 Composition antimycosique sous forme de creme au bifonazole, a forte liberation de substance active

Country Status (19)

Country Link
JP (1) JPS59184106A (fr)
KR (1) KR840008284A (fr)
AU (1) AU564956B2 (fr)
BE (1) BE899278A (fr)
CA (1) CA1212327A (fr)
CH (1) CH660126A5 (fr)
CY (1) CY1358A (fr)
DE (1) DE3311701A1 (fr)
ES (3) ES8503947A1 (fr)
FR (1) FR2543435B1 (fr)
GB (1) GB2137091B (fr)
GR (1) GR81485B (fr)
IT (1) IT1173761B (fr)
KE (1) KE3704A (fr)
LU (1) LU85271A1 (fr)
PH (1) PH20420A (fr)
PT (1) PT78313B (fr)
SE (1) SE8401748L (fr)
ZA (1) ZA842337B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ZA934007B (en) * 1992-06-08 1994-03-09 Schering Plough Healthcare Stable imidazole anti-fungal powder compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
CY1358A (en) 1987-08-07
SE8401748L (sv) 1984-10-01
CA1212327A (fr) 1986-10-07
IT1173761B (it) 1987-06-24
ES8601692A1 (es) 1985-11-16
GB8408067D0 (en) 1984-05-10
GR81485B (fr) 1984-12-11
JPS59184106A (ja) 1984-10-19
DE3311701A1 (de) 1984-10-04
ES8601693A1 (es) 1985-11-16
SE8401748D0 (sv) 1984-03-29
CH660126A5 (de) 1987-03-31
BE899278A (fr) 1984-10-01
AU2623684A (en) 1984-10-04
PH20420A (en) 1987-01-05
PT78313A (en) 1984-04-01
ES530846A0 (es) 1985-04-16
KE3704A (en) 1987-03-27
IT8420303A0 (it) 1984-03-29
ZA842337B (en) 1984-11-28
PT78313B (en) 1986-06-02
GB2137091B (en) 1986-10-01
ES539289A0 (es) 1985-11-16
ES8503947A1 (es) 1985-04-16
LU85271A1 (de) 1984-11-14
KR840008284A (ko) 1984-12-14
GB2137091A (en) 1984-10-03
ES539290A0 (es) 1985-11-16
AU564956B2 (en) 1987-09-03
FR2543435A1 (fr) 1984-10-05

Similar Documents

Publication Publication Date Title
AR240251A1 (es) Metodo para preparar una composicion para tratamiento de infecciones virales y un metodo para sintetizar 3' azido 2', 3' dideoxiuridina destinada a la preparacion de dicha composicion.
NO167213C (no) Komposittartikkel i form av en innlukningsgjenstand, samtfremgangsmaate for sulfonering av den innvendige overflateav en innlukningsgjenstand.
IT8025076A0 (it) Procedimento e composizione per la colorazione di sostanze contenenti cheratina.
HUT44414A (en) Pesticide comprising 1,2,3,6 tetrahydro-5-nitropyrimidine derivatives as active substance and process for preparing the active substance
FR2665894B1 (fr) Alpha- et beta-octogenes sous forme granulee et stabilisee.
NO873108D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-benzodiazepiner.
MX7700E (es) Procedimiento para la preparacion de 5-amino-3-oxo-4-(substituido-fenilo)-2-3,dihidrofurano y sus derivados
DE3886371D1 (de) Herstellung des hblv-virus in der hsb-2 zell-linie.
FR2543435B1 (fr) Composition antimycosique sous forme de creme au bifonazole, a forte liberation de substance active
IT1216141B (it) Composizione cosmetica rigenerante la pelle e procedimento per la sua preparazione.
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
IT1171387B (it) Derivati steroidici 20-isonitrili 17(20)-insaturi, procedimento per la loro preparazione, e loro applicazione nella preparazione degli sterioidi 17alfa-idrcssi-20-chetonici
IT8422082A0 (it) Procedimento e composizioni per la colorazione di fanere.
NO882335D0 (no) Fremgangsmaate for fremstilling av 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener.
IT8322401A0 (it) Procedimento per la preparazione della 5-(e)-(2-bromovinil)-2'--desossiuri dina e dei suoi derivati, ederivati della 5-(e)-(2--bromovinil)-2'-desossiuri dina.
HUT41225A (en) Insectide and acaricide compositions containing 1,3-diphenyl-1,2,4-triazole derivatives as active substances and process for preparing the active substances
GB2037289B (en) Nucleoside derivatives and an antileukemial agent containing the same as an active ingredient
BR8901200A (pt) Composicao anti-espuma solida,composicao agroquimica e processo para preparacao das mesmas
IT8722055A0 (it) Procedimento per la preparazione di idantoine 5-ariliden e alchilidensostituite.
FR2529195B1 (fr) Engrais sous forme de batonnets
IT1125603B (it) Procedimento per la preparazione di omega-lattami,in particolare caprolattame
DE3852692D1 (de) Integriertes Schaltkreis-Bauelement vom Typ "Master Slice" und dessen Verwendung.
ES508153A0 (es) "perfeccionamientos introducidos en la estructura y fabricacion de bastidores para silenciador".
DK483584A (da) Azolyl-tetrahydrofuran-2-yliden-methan-derivater, deres fremstillingog anvendelse som fungicider samt ved fremstillingen anvendelige udgangsmaterialer
NO153731C (no) Fremgangsmaate for isolering av fysiologisk aktive pterocarpanforbindelser i krystallinsk form.